OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy

OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy

Bibliographic Details
Main Authors:	G. Bozzi, S. Watters, F.R. Simonetti, E. Anderson, R. Gorelick, W. Shao, J. Bell, C. Rehm, R. Dewar, R. Yarchoan, T. Uldrick, F. Maldarelli
Format:	Article
Language:	English
Published:	Elsevier 2016-07-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020310128

Similar Items

Evidence of ongoing HIV replication during suppressive antiretroviral therapy
by: L. Bertoni Giron, et al.
Published: (2015-12-01)

OA4-5 LB SIV persistence in ART-treated infant rhesus macaques
by: M. Mavigner, et al.
Published: (2016-07-01)

Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues
by: F. Maldarelli, et al.
Published: (2019-12-01)

35 Therapy with the immunomodulatory agent pomalidomide does not lead to changes in HIV-1 viral populations in vivo
by: S.A. Watters, et al.
Published: (2016-07-01)

In vivo analysis of HIV from an occupational exposure to laboratory adapted HIV-IIIB with 20-year follow-up: implications for reservoir formation
by: C. Lange, et al.
Published: (2019-12-01)

OAS1, OAS2 and OAS3 restrict intracellular M. tb replication and enhance cytokine secretion
by: Gina Leisching, et al.
Published: (2019-03-01)

CD8<sup>+</sup> T Cells in OA Knee Joints Are Differentiated into Subsets Depending on OA Stage and Compartment
by: Hadrian Platzer, et al.
Published: (2022-05-01)

OA03-06 LB. Unique stimulatory properties of myeloid dendritic cells in individuals with "elite" HIV-1 control
by: Borges L, et al.
Published: (2009-10-01)

OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial
by: Self SG, et al.
Published: (2009-10-01)

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
by: Elizabeth M. Anderson, et al.
Published: (2020-01-01)

No evidence for ongoing HIV replication in lymph nodes during suppressive ART
by: W.R. McManus, et al.
Published: (2017-12-01)

OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
by: E. Kroon, et al.
Published: (2016-07-01)

OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro
by: Barré-Sinoussi F, et al.
Published: (2009-10-01)

Flavivirus Concentrates Host ER in Main Replication Compartments to Facilitate Replication
by: Yali Ci, et al.
Published: (2023-12-01)

Psychological profiles in adults with knee OA-related pain: a replication study
by: Alisa J. Johnson, et al.
Published: (2021-12-01)

Herpesvirus Replication Compartments: Dynamic Biomolecular Condensates?
by: Enrico Caragliano, et al.
Published: (2022-05-01)

P 4.2 – 00029 Innate Immune Correlates of Cell-Associated HIV RNA And DNA During Long-Term Suppressive ART
by: C.-Y. Lau, et al.
Published: (2022-12-01)

OP 2.4 – 00145 No Evidence of Ongoing Viral Replication in SIV-Infected Macaques on Combination Antiretroviral Therapy Initiated in the Chronic Phase of Infection Despite Elevated Residual Plasma Viral Loads
by: G.Q. Del Prete, et al.
Published: (2022-12-01)

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
by: Chiu J, et al.
Published: (2009-10-01)

HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence
by: Frank Maldarelli
Published: (2015-10-01)

Replication Compartments—The Great Survival Strategy for Epstein–Barr Virus Lytic Replication
by: Atsuko Sugimoto
Published: (2022-04-01)

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial
by: Francis D, et al.
Published: (2009-10-01)

Formation of the Legionella Replicative Compartment at the Crossroads of Retrograde Trafficking
by: Kevin Bärlocher, et al.
Published: (2017-11-01)

Walking time measures for evaluating OA of the knee
by: R. Marks
Published: (1994-02-01)

Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial
by: Fahmida Shaik, et al.
Published: (2018-10-01)

HIV replication and evolution in patients on highly active antiretroviral therapy
by: Siliciano Robert F
Published: (2006-12-01)

Continuous DNA replication is required for late gene transcription and maintenance of replication compartments in gammaherpesviruses.
by: Dajiang Li, et al.
Published: (2018-05-01)

Activation and Antagonism of the OAS–RNase L Pathway
by: Susan R. Weiss
Published: (2020-06-01)

Erratum to: HIV integration sites in latently infected cell lines: evidence of ongoing replication
by: Jori Symons, et al.
Published: (2017-03-01)

Aligning European OA policies with the Horizon 2020 OA policy
by: Mafalda Picarra, et al.
Published: (2015-11-01)

Viral dew: Phase separation and the formation of viral replication compartments.
by: Jens B Bosse, et al.
Published: (2023-02-01)

Viral dew: Phase separation and the formation of viral replication compartments
by: Jens B. Bosse, et al.
Published: (2023-02-01)

Replication Compartments of DNA Viruses in the Nucleus: Location, Location, Location
by: Matthew Charman, et al.
Published: (2020-01-01)

Herpesvirus Replication Compartments Originate with Single Incoming Viral Genomes
by: O. Kobiler, et al.
Published: (2011-12-01)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
by: Mark N. Polizzotto, et al.
Published: (2017-08-01)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
by: Mark N. Polizzotto, et al.
Published: (2012-03-01)

Host Cell S Phase Restricts <italic toggle="yes">Legionella pneumophila</italic> Intracellular Replication by Destabilizing the Membrane-Bound Replication Compartment
by: Dennise A. de Jesús-Díaz, et al.
Published: (2017-09-01)

S03-06 OA. Rapid perforin upregulation by CD8 T cells in elite controllers as a correlate of immune-mediated control of HIV replication
by: Kaul R, et al.
Published: (2009-10-01)

Effect of NiO nanoparticles on duplex stainless steel processed via DED-LB and PBF-LB
by: Nahr, Florian, et al.
Published: (2024)

Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer
by: T.S. Uldrick, et al.
Published: (2017-12-01)